Document is current
Any future updates will be listed below
-
Authors
Tirtakusuma, Ricky
Ghonim, Mohamed A. https://orcid.org/0000-0001-9404-2698
Schattgen, Stefan https://orcid.org/0000-0002-6860-5079
Muller, Bradley
Van de Velde, Lee Ann
Khan, Tanya M.
Crawford, Jeremy Chase https://orcid.org/0000-0003-4096-6048
Ma, Jing
Abdelhamed, Sherif
Vegesana, Kasi
Awad, Walid
Allen, E. Kaitlynn
Iacobucci, Ilaria https://orcid.org/0000-0003-2008-1365
Mullighan, Charles G. https://orcid.org/0000-0002-1871-1850
Klco, Jeffery M. https://orcid.org/0000-0003-2961-6960
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA265009, P30 CA021765, R35 CA197695)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R01AI136514)
American Lebanese Syrian Associated Charities
- License Information
-
More Information
Article History
Received: 3 April 2025
Revised: 20 June 2025
Accepted: 9 July 2025
First Online: 24 July 2025
Competing interests
: PGT is on the Scientific Advisory Board of Immunoscape and Shennon Bio, received personal fees and research support from Elevate Bio, and consulted for 10X, Illumina, Pfizer, Cytoagents, Sanofi, Merck, and JNJ. CGM received research funding from AbbVie and Pfizer, honoraria from Amgen and Illumina, and royalty payments from Cyrus. CGM is on an advisory board for Illumina.
